Insulet
PODD
$174.43
Share price
0.58%
Change (1 day)
-44.60%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Operating Margin for Insulet (PODD)
Operating Margin as of May 2024 (TTM): 0.75%
According to Insulet's latest financial reports and stock price the company's current Operating Margin is 0.75%. At the end of 2022 the company had an Operating Margin of 0.75%.
Operating Margin history for Insulet from 2006 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 0.75% | -59.76% |
| 2021 | 1.87% | 73.95% |
| 2020 | 1.07% | -45.4% |
| 2019 | 1.96% | 111.92% |
| 2018 | 0.93% | -116.18% |
| 2017 | -5.73% | -21.59% |
| 2016 | -7.31% | -68.59% |
| 2015 | -23.26% | 30.78% |
| 2014 | -17.79% | -2.06% |
| 2013 | -18.16% | -25.68% |
| 2012 | -24.44% | -34.77% |
| 2011 | -37.47% | 6.22% |
| 2010 | -35.27% | -60.76% |
| 2009 | -89.89% | -63.72% |
| 2008 | -247.77% | -38.47% |
| 2007 | -402.65% | -57.43% |
| 2006 | -945.81% | -97.8% |
| 2005 | -43,010.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 2,950.67% | 🇺🇸 USA |
 Abbott Laboratories ABT | 15.60% | 1,980.00% | 🇺🇸 USA |
 Medtronic MDT | 17.17% | 2,189.33% | 🇮🇪 Ireland |
 Eli Lilly LLY | 24.66% | 3,188.00% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | -25.16% | -3,454.67% | 🇺🇸 USA |
 ICU Medical
ICUI | -5.01% | -768.00% | 🇺🇸 USA |
 DexCom DXCM | 13.43% | 1,690.67% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.